Dan Burgess
North America, Massachusetts, United States, Boston
Description
Daniel Burgess joined SV Life Sciences as a Venture Partner in 2014.
Prior to joining SV, Mr. Burgess was founder, President and CEO of ...
Investor Profile
Dan Burgess has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series D, Series B rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Medical Device.
Stage Focus
- Series D (50%)
- Series B (50%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Medical Device
- Biopharma
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
